ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2246

Impact of Patient Education Tool to Increase Cardiovascular Risk Konwledge, Attitudes, and Behaviors in Patietns with Rheumatoid Arthritis

Lisa Zickuhr1, William Messner2, Abby Abelson3 and M. Elaine Husni4, 1Rheumatology, Cleveland Clinic Foundation, Cleveland, OH, 2Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, 3Department of Rheumatologic & Immunologic Disease, Cleveland Clinic Foundation, Cleveland, OH, 4Cleveland Clinic, Cleveland, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cardiovascular disease, Education, patient and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Rheumatoid arthritis (RA) raises cardiovascular disease (CVD) risk, yet RA patients underestimate their personal risk. The principle of self-management posits patients will be self-motivated stewards of their health if they have the knowledge, resources, and support to influence their care. We assess how an education handout aimed at improving RA patients’ self-management of CVD risk changes their knowledge, attitudes, and behaviors. We hypothesize it will improve knowledge with little effect on attitudes and behaviors.

Methods: We prospectively recruited RA patients from an outpatient general rheumatology clinic to read a patient education handout and answer three surveys at time of enrollment (week 0), week 1, and week 8. We distributed education handouts after completion of the week 0 survey. Surveys at weeks 0 and 8 contained questions about behavioral risk factors from the Centers for Disease Control’s Behavioral Risk Factor Surveillance System, novel Likert scales ranking patients’ attitudes about CVD risk, and the Heart Disease Fact Questionnaire-Rheumatoid Arthritis (HDFQ-RA), a validated measurement of RA patients’ knowledge of general CVD and RA-specific CVD risk. The survey at week 1 was the HDFQ-RA. Wilcoxon signed-rank test (α=0.05) analyzed changes in HDFQ-RA scores and Likert rankings, while McNemar’s test (α=0.05) analyzed changes in behaviors.

Results: A total of 38 participants completed all surveys and read the handout. Most patients were female (89%), aged 61.5 (±11.9) years old with a mean RA duration of 15.3 (±13.3) years. Based on total HDFQ-RA scores, both general and RA-specific CVD knowledge significantly improved at week 1 and was sustained at week 8 (table 1).

Table 1:

Survey

Mean Change

P-Value

Total Heart Disease Fact Questionnaire-Rheumatoid Arthritis (HDFQ-RA) Score (13 questions)

Week 0 vs Week 1

1.342

<0.001

Week 0 vs Week 8

1.421

<0.001

Week 1 vs Week 8

0.079

0.549

General Cardiovascular Disease (CVD) Risk Knowledge from HDFQ-RA Score (9 questions)

Week 0 vs Week 1

0.895

<0.001

Week 0 vs Week 8

0.816

<0.001

Week 1 vs Week 8

-0.079

0.407

Rheumatoid Arthritis-Specific CVD Risk Knowledge from HDFQ-RA Score (4 questions)

Week 0 vs Week 1

0.447

0.015

Week 0 vs Week 8

0.605

<0.001

Week 1 vs Week 8

0.158

0.041

Based on Likert scales, only attitudes regarding the influence of RA disease activity on CVD risk changed (p=0.012). A total of 23 of the 38 participants (73.7%) stated the handout motivated them to make lifestyle changes, and a significant change was noted in exercise at week 8 (p=0.016), but not in smoking cessation or diet (p>0.99).

Conclusion: A patient education handout improved RA patients’ self-management of CVD risk, not only enhancing knowledge but also improving lifestyle self-management, as patients increased their exercise habits over an 8-week period.  Patients also believed that RA management is more important in mitigating their CVD risk after reading the handout.  This data suggests a patient handout can effectively change patients’ understanding of CV risks and influence certain lifestyle factors, such as exercise. Further study is needed to review self-management strategies that may further augment knowledge, attitudes, and behaviors of CVD in RA patients and potentially improve CV risk factors.

 


Disclosure: L. Zickuhr, None; W. Messner, None; A. Abelson, None; M. E. Husni, AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, Janssen, Novartis, Regeneron, UCB, 5,Pfizer Inc, 6,PASE Questionnaire, 7.

To cite this abstract in AMA style:

Zickuhr L, Messner W, Abelson A, Husni ME. Impact of Patient Education Tool to Increase Cardiovascular Risk Konwledge, Attitudes, and Behaviors in Patietns with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/impact-of-patient-education-tool-to-increase-cardiovascular-risk-konwledge-attitudes-and-behaviors-in-patietns-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-patient-education-tool-to-increase-cardiovascular-risk-konwledge-attitudes-and-behaviors-in-patietns-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology